108 related articles for article (PubMed ID: 19342366)
21. A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy.
Chen CH; Li SH
J Thorac Dis; 2017 Jun; 9(6):1446-1449. PubMed ID: 28740654
[No Abstract] [Full Text] [Related]
22. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment.
Jiang M; Zhang WW; Liu P; Yu W; Liu T; Yu J
Front Immunol; 2017; 8():70. PubMed ID: 28228755
[TBL] [Abstract][Full Text] [Related]
24. Molecular signaling involving intrinsically disordered proteins in prostate cancer.
Russo A; Manna SL; Novellino E; Malfitano AM; Marasco D
Asian J Androl; 2016; 18(5):673-81. PubMed ID: 27212129
[TBL] [Abstract][Full Text] [Related]
25. 15-Deoxy-Δ(12,14)-prostaglandin J2 Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells.
Trindade-da-Silva CA; Reis CF; Vecchi L; Napimoga MH; Sperandio M; Matias Colombo BF; Alves PT; Ward LS; Ueira-Vieira C; Goulart LR
PPAR Res; 2016; 2016():4106297. PubMed ID: 27190500
[TBL] [Abstract][Full Text] [Related]
26. The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation.
Meng L; Bai Z; He S; Mochizuki K; Liu Y; Purushe J; Sun H; Wang J; Yagita H; Mineishi S; Fung H; Yanik GA; Caricchio R; Fan X; Crisalli LM; Hexner EO; Reshef R; Zhang Y; Zhang Y
J Immunol; 2016 Feb; 196(3):1070-80. PubMed ID: 26712946
[TBL] [Abstract][Full Text] [Related]
27. Proinflammatory cytokine interleukin-6 in prostate carcinogenesis.
Culig Z
Am J Clin Exp Urol; 2014; 2(3):231-8. PubMed ID: 25374925
[TBL] [Abstract][Full Text] [Related]
28. SOCS proteins in regulation of receptor tyrosine kinase signaling.
Kazi JU; Kabir NN; Flores-Morales A; Rönnstrand L
Cell Mol Life Sci; 2014 Sep; 71(17):3297-310. PubMed ID: 24705897
[TBL] [Abstract][Full Text] [Related]
29. SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.
Hoefer J; Kern J; Ofer P; Eder IE; Schäfer G; Dietrich D; Kristiansen G; Geley S; Rainer J; Gunsilius E; Klocker H; Culig Z; Puhr M
Endocr Relat Cancer; 2014 Apr; 21(2):175-87. PubMed ID: 24280133
[TBL] [Abstract][Full Text] [Related]
30. miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.
Amodio N; Bellizzi D; Leotta M; Raimondi L; Biamonte L; D'Aquila P; Di Martino MT; Calimeri T; Rossi M; Lionetti M; Leone E; Passarino G; Neri A; Giordano A; Tagliaferri P; Tassone P
Cell Cycle; 2013 Dec; 12(23):3650-62. PubMed ID: 24091729
[TBL] [Abstract][Full Text] [Related]
31. SOCS, inflammation, and cancer.
Inagaki-Ohara K; Kondo T; Ito M; Yoshimura A
JAKSTAT; 2013 Jul; 2(3):e24053. PubMed ID: 24069550
[TBL] [Abstract][Full Text] [Related]
32. Expression of SOCSs in human prostate cancer and their association in prognosis.
Zhu JG; Dai QS; Han ZD; He HC; Mo RJ; Chen G; Chen YF; Wu YD; Yang SB; Jiang FN; Chen WH; Sun ZL; Zhong WD
Mol Cell Biochem; 2013 Sep; 381(1-2):51-9. PubMed ID: 23666742
[TBL] [Abstract][Full Text] [Related]
33. Identification of miR-30d as a novel prognostic maker of prostate cancer.
Kobayashi N; Uemura H; Nagahama K; Okudela K; Furuya M; Ino Y; Ito Y; Hirano H; Inayama Y; Aoki I; Nagashima Y; Kubota Y; Ishiguro H
Oncotarget; 2012 Nov; 3(11):1455-71. PubMed ID: 23231923
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course.
Zhang C; Wang J; Lü G; Li J; Lu X; Mantion G; Vuitton DA; Wen H; Lin R
PLoS One; 2012; 7(1):e30127. PubMed ID: 22253905
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6: a multifunctional targetable cytokine in human prostate cancer.
Culig Z; Puhr M
Mol Cell Endocrinol; 2012 Sep; 360(1-2):52-8. PubMed ID: 21664423
[TBL] [Abstract][Full Text] [Related]
36. Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition.
Chiu WT; Lee HT; Huang FJ; Aldape KD; Yao J; Steeg PS; Chou CY; Lu Z; Xie K; Huang S
Cancer Res; 2011 Jul; 71(14):4932-43. PubMed ID: 21622714
[TBL] [Abstract][Full Text] [Related]
37. Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development.
Scutti JA; Matsuo AL; Pereira FV; Massaoka MH; Figueiredo CR; Moreira DF; Belizário JE; Travassos LR
Transl Oncol; 2011 Apr; 4(2):101-9. PubMed ID: 21461173
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic of prostate cancer: conventional and molecular or cell biological methods].
Susani M; Kenner L; Culig Z
Pathologe; 2009 Dec; 30 Suppl 2():154-7. PubMed ID: 19802609
[TBL] [Abstract][Full Text] [Related]
39. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Neuwirt H; Puhr M; Santer FR; Susani M; Doppler W; Marcias G; Rauch V; Brugger M; Hobisch A; Kenner L; Culig Z
Am J Pathol; 2009 May; 174(5):1921-30. PubMed ID: 19342366
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.
Puhr M; Santer FR; Neuwirt H; Susani M; Nemeth JA; Hobisch A; Kenner L; Culig Z
Cancer Res; 2009 Sep; 69(18):7375-84. PubMed ID: 19738059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
